s6y
Company name or ticker
Search
4D Molecular Therapeutics, Inc.
4
Kirn David: Statement of changes in beneficial ownership of securities
Filed
Wednesday, August 5, 2026
Period
Aug 4, 2026
Accession number
0001193125-26-335115
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header